Prognostic Significance of PUMA in Pancreatic Ductal Adenocarcinoma

Author： Du QH Zhang KJ Jiao XL Zhao J Zhang M Yan BM Xu YB

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.40, Iss.6, 2012-11, pp. : 2066-2072

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibody Therapies Targeting Pancreatic Ductal Adenocarcinoma

Current Drug Discovery Technologies, Vol. 3, Iss. 4, 2006-12 ,pp. : 231-243

Bentham Science Publishers

Access to resources Recommend Favorite

Can pharmacogenomics guide effective anticancer therapy in pancreatic ductal adenocarcinoma?

By Krell Jonathan Frampton Adam E Jiao Long R Stebbing Justin

Pharmacogenomics, Vol. 13, Iss. 9, 2012-07 ,pp. : 977-979

Future Medicine

Access to resources Recommend Favorite

The Immunohistochemical Assessment of HPV Related Adenocarcinoma: Pathologic and Clinical Prognostic Significance

Current Pharmaceutical Design, Vol. 19, Iss. 8, 2013-03 ,pp. : 1430-1438

Bentham Science Publishers

Access to resources Recommend Favorite

Pancreatic Adenocarcinoma

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 10, 2007-11 ,pp. : 998-998

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma

By Hou Ya-Chin Chao Ying-Jui Tung Hui-Ling Wang Hao-Chen Shan Yan-Shen

Cancer, Vol. 120, Iss. 17, 2014-09 ,pp. : 2766-2777

Blackwell Publishing

Access to resources Recommend Favorite